World Wires · story 20785 · unverified · 1 source(s)

Nurix Therapeutics Announces Second Research Term Extension for Oncology Program Under Collaboration with Gilead Sciences

Two-year extension builds on productive relationship established in 2019

Open in the desk

Coverage

• Nurix Therapeutics Announces Second Research Term Extension for Oncology Program Under Collaboration with Gilead Sciences GlobeNewswire: public companies · tier D · clear net · 2026-10-05 11:00 UTC

What this site indexes